250 related articles for article (PubMed ID: 16627863)
1. Inhaled L-arginine improves exhaled nitric oxide and pulmonary function in patients with cystic fibrosis.
Grasemann H; Kurtz F; Ratjen F
Am J Respir Crit Care Med; 2006 Jul; 174(2):208-12. PubMed ID: 16627863
[TBL] [Abstract][Full Text] [Related]
2. A randomized controlled trial of inhaled L-arginine in patients with cystic fibrosis.
Grasemann H; Tullis E; Ratjen F
J Cyst Fibros; 2013 Sep; 12(5):468-74. PubMed ID: 23333044
[TBL] [Abstract][Full Text] [Related]
3. Increased arginase activity in cystic fibrosis airways.
Grasemann H; Schwiertz R; Matthiesen S; Racké K; Ratjen F
Am J Respir Crit Care Med; 2005 Dec; 172(12):1523-8. PubMed ID: 16166623
[TBL] [Abstract][Full Text] [Related]
4. Oral L-arginine supplementation in cystic fibrosis patients: a placebo-controlled study.
Grasemann H; Grasemann C; Kurtz F; Tietze-Schillings G; Vester U; Ratjen F
Eur Respir J; 2005 Jan; 25(1):62-8. PubMed ID: 15640324
[TBL] [Abstract][Full Text] [Related]
5. A pilot study of oral L-arginine in cystic fibrosis.
Everard ML; Donnelly D
J Cyst Fibros; 2005 Mar; 4(1):67-9. PubMed ID: 15752684
[TBL] [Abstract][Full Text] [Related]
6. Effect of oral arginine supplementation on exhaled nitric oxide concentration in sickle cell anemia and acute chest syndrome.
Sullivan KJ; Kissoon N; Sandler E; Gauger C; Froyen M; Duckworth L; Brown M; Murphy S
J Pediatr Hematol Oncol; 2010 Oct; 32(7):e249-58. PubMed ID: 20724949
[TBL] [Abstract][Full Text] [Related]
7. Dornase alpha and exhaled NO in cystic fibrosis.
Grasemann H; Lax H; Treseler JW; Colin AA
Pediatr Pulmonol; 2004 Nov; 38(5):379-85. PubMed ID: 15390350
[TBL] [Abstract][Full Text] [Related]
8. Low levels of exhaled nitric oxide are associated with impaired lung function in cystic fibrosis.
Keen C; Gustafsson P; Lindblad A; Wennergren G; Olin AC
Pediatr Pulmonol; 2010 Mar; 45(3):241-8. PubMed ID: 20146368
[TBL] [Abstract][Full Text] [Related]
9. Effect of growth hormone therapy on nitric oxide formation in cystic fibrosis patients.
Grasemann C; Ratjen F; Schnabel D; Reutershahn E; Vester U; Grasemann H
Eur Respir J; 2008 Apr; 31(4):815-21. PubMed ID: 18094013
[TBL] [Abstract][Full Text] [Related]
10. Characteristics of flow dependency of nitric oxide in exhaled air in children with cystic fibrosis and asthma.
Beck J; Griese M; Latzin P; Reinhardt D
Eur J Med Res; 1999 Aug; 4(8):335-40. PubMed ID: 10471545
[TBL] [Abstract][Full Text] [Related]
11. Exhaled breath condensate pH and exhaled nitric oxide in allergic asthma and in cystic fibrosis.
Ojoo JC; Mulrennan SA; Kastelik JA; Morice AH; Redington AE
Thorax; 2005 Jan; 60(1):22-6. PubMed ID: 15618578
[TBL] [Abstract][Full Text] [Related]
12. Short-term efficacy of ultrasonically nebulized hypertonic saline in cystic fibrosis.
Eng PA; Morton J; Douglass JA; Riedler J; Wilson J; Robertson CF
Pediatr Pulmonol; 1996 Feb; 21(2):77-83. PubMed ID: 8882210
[TBL] [Abstract][Full Text] [Related]
13. Acute effects of aerosolized S-nitrosoglutathione in cystic fibrosis.
Snyder AH; McPherson ME; Hunt JF; Johnson M; Stamler JS; Gaston B
Am J Respir Crit Care Med; 2002 Apr; 165(7):922-6. PubMed ID: 11934715
[TBL] [Abstract][Full Text] [Related]
14. Pilot study of safety and tolerability of inhaled hypertonic saline in infants with cystic fibrosis.
Subbarao P; Balkovec S; Solomon M; Ratjen F
Pediatr Pulmonol; 2007 May; 42(5):471-6. PubMed ID: 17436328
[TBL] [Abstract][Full Text] [Related]
15. Nasal and exhaled nitric oxide is reduced in adult patients with cystic fibrosis and does not correlate with cystic fibrosis genotype.
Thomas SR; Kharitonov SA; Scott SF; Hodson ME; Barnes PJ
Chest; 2000 Apr; 117(4):1085-9. PubMed ID: 10767244
[TBL] [Abstract][Full Text] [Related]
16. Nitric oxide in cystic fibrosis.
de Winter-de Groot KM; van der Ent CK
J Cyst Fibros; 2005 Aug; 4 Suppl 2():25-9. PubMed ID: 15982933
[TBL] [Abstract][Full Text] [Related]
17. Nitric oxide deficiency contributes to impairment of airway relaxation in cystic fibrosis mice.
Mhanna MJ; Ferkol T; Martin RJ; Dreshaj IA; van Heeckeren AM; Kelley TJ; Haxhiu MA
Am J Respir Cell Mol Biol; 2001 May; 24(5):621-6. PubMed ID: 11350833
[TBL] [Abstract][Full Text] [Related]
18. Effect of L-arginine infusion on airway NO in cystic fibrosis and primary ciliary dyskinesia syndrome.
Grasemann H; Gärtig SS; Wiesemann HG; Teschler H; Konietzko N; Ratjen F
Eur Respir J; 1999 Jan; 13(1):114-8. PubMed ID: 10836334
[TBL] [Abstract][Full Text] [Related]
19. Effect of nebulised L- and D-arginine on exhaled nitric oxide in steroid naive asthma.
Chambers DC; Ayres JG
Thorax; 2001 Aug; 56(8):602-6. PubMed ID: 11462061
[TBL] [Abstract][Full Text] [Related]
20. Asymmetric dimethylarginine contributes to airway nitric oxide deficiency in patients with cystic fibrosis.
Grasemann H; Al-Saleh S; Scott JA; Shehnaz D; Mehl A; Amin R; Rafii M; Pencharz P; Belik J; Ratjen F
Am J Respir Crit Care Med; 2011 May; 183(10):1363-8. PubMed ID: 21278301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
